Keyphrases
Prostate Cancer
59%
Androgen Deprivation Therapy
42%
Erectile Dysfunction
34%
Randomized Clinical Trial
31%
Confidence Interval
27%
Testosterone
24%
Radical Prostatectomy
24%
Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
22%
Abiraterone Acetate
21%
Metastatic Castration-resistant Prostate Cancer (mCRPC)
20%
Prostate
19%
Sexual Behavior
19%
Enzalutamide
19%
Localized Prostate Cancer
17%
Prednisone
16%
Quality of Life
15%
Orchiectomy
15%
Football
14%
Randomized Trial
14%
Denmark
14%
Older Men
13%
Usual Care
13%
Advanced Prostate Cancer
11%
30-s Chair-stand Test
11%
Health-related Quality of Life
11%
Progressive Resistance Training
11%
Metabolic Changes
11%
Brachytherapy
11%
Randomized Controlled Trial
10%
Abiraterone
10%
Adverse Effects
10%
Meta-analysis
10%
Prostate Radiotherapy
10%
Systematic Meta-analysis
9%
Functional Outcome
9%
Urinary Tract Cancer
9%
Male Infertility
9%
Quality of Life Changes
9%
Prostate Cancer Patients
9%
Biomarker Potential
9%
Multicenter Randomized Controlled Trial
9%
Luteinizing Hormone
9%
Testosterone Undecanoate
9%
Sexually Active
9%
Community-based
9%
Herlev
8%
Prostate-specific Antigen
8%
Urinary Incontinence
8%
Erectile Function
8%
Hypogonadism
7%
Medicine and Dentistry
Prostate Cancer
100%
Androgen Deprivation Therapy
42%
Erectile Dysfunction
35%
Prostatectomy
28%
Quality of Life
27%
Randomized Clinical Trial
21%
Randomized Controlled Trial
20%
Side Effect
18%
Orchiectomy
16%
Prevalence
15%
Urology
15%
Cancer Therapy
14%
Neoplasm
14%
Gonadorelin Agonist
14%
Resistance Training
13%
Abiraterone Acetate
13%
Adverse Event
12%
Observational Study
11%
Symptom
11%
Meta-Analysis
11%
Abiraterone
11%
Androgen
10%
Diagnosis
10%
Castration Resistant Prostate Cancer
9%
Enzalutamide
9%
Systematic Review
9%
Clinical Study
9%
Prednisone
9%
Urinary Tract Cancer
9%
Brachytherapy
9%
Hypogonadism
9%
Microhematuria
8%
Testosterone Undecanoate
8%
Orgasm
7%
Triptorelin
7%
Phosphodiesterase V Inhibitor
7%
Overall Survival
7%
Urine Incontinence
7%
Adipose Tissue
6%
Malignant Neoplasm
6%
Bladder Cancer
6%
Patient Experience
6%
Care Group
6%
Odds Ratio
6%
Lean Body Weight
6%
Vitamin D
6%
Isotopes of Calcium
6%
Androgen Therapy
6%
Urologist
5%
Exercise
5%